title: Diagnosis and Management of Endomyocardial Fibrosis.
abstract: Endomyocardial fibrosis (EMF) remains an important cause of restrictive cardiomyopathy worldwide. Patients cluster in specific geographic locations and are almost universally living in extreme poverty. Specific etiology remains elusive and is likely multifactorial. Untreated EMF has a very poor prognosis. Medical management can mitigate symptoms for a time but has no curative benefit. Early surgical interventions may improve survival but are not readily available in most EMF-endemic regions. Increased awareness, advocacy, and research are needed to further understand this neglected tropical cardiomyopathy and to improve survival of those affected.
authors.affiliation: Division of Cardiology, Children's National Health System, 111 Michigan Avenue, Northwest, Washington, DC 20010, USA. Electronic address: abeaton@childrensnational.org.
authors.forename: Andrea
authors.initials: A
authors.lastname: Beaton
authors.affiliation: Chronic and Non-Communicable Disease Division, National Health Institutes and Eduardo Mondlane University, Avenida do Zimbábew, Maputo, Mozambique.
authors.forename: Ana Olga
authors.initials: AO
authors.lastname: Mocumbi
mesh_terms: D019468:Disease Management; D004719:Endomyocardial Fibrosis / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D014943:Global Health; D006801:Humans; D015994:Incidence; D011379:Prognosis
keywords: Endomyocarial fibrosis; Heart failure; Neglected diseases; Restrictive cardiomyopathy